Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-23, Stock:ABBV, The news for the past five days is as follows:
2019-10-16: NEWS1: T Rowe Price Equity Income Fund's Top 5 Buys in the 3rd Quarter.NEWS2: Jim Cramer: Where Can You Still Get Some Growth and a Big Yield?.NEWS3: Is AbbVie (ABBV) Stock Undervalued Right Now?.NEWS4: Here is Why Growth Investors Should Buy AbbVie (ABBV) Now.NEWS5: Top Ranked Momentum Stocks to Buy for October 16th.
2019-10-17: NEWS1: Why Health Care Stocks Can Rebound Despite 2020 Election Turmoil.NEWS2: Novartis' Jakavi Meets Primary Goal in Phase III for GVHD.NEWS3: The Long Decline in AbbVie Is Over.NEWS4: Top Ranked Income Stocks to Buy for October 17th.
2019-10-18: NEWS1: AstraZeneca's Breast Cancer Candidate BLA Gets Priority Review.NEWS2: Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow.NEWS3: AbbVie Receives CHMP Positive Opinion for Upadacitinib (RINVOQ™) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis.
2019-10-21: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: CEO Confidence Is Down, Goldman Sachs Says. Look for a Turnaround in 2020..NEWS3: What's in Store for Healthcare ETFs in Q3 Earnings?.
2019-10-22: NEWS1: Goldman Sachs: 3 High-Yield Dividend Stocks With Growth on the Horizon.NEWS2: Biogen (BIIB) Beats on Q3 Earnings, Eyes FDA Nod for Aducanumab.NEWS3: How to identify U.S. stocks with attractive growth potential.

Answer: Decrease